Regional Insights and Engagement Director, Lung, Southeast

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Regional Insights and Engagement Director, Southeast is a field-based position focused on working closely with Lung Cancer Key Opinion Leaders (KOLs) at select institutions and accounts within the defined geography. This person is a RevMed clinical and product expert for Key Opinion Leaders and ensures that cross-functional resources are made available as appropriate.

In this role, you will be a member of the commercial development team, and you will work closely with marketing, medical affairs, field sales, insights and analytics and other cross functional colleagues. You will help inform brand strategy, develop and execute KOL tactics and you will be evaluated in conjunction with individual performance and brand KPIs This role will cover major academic institutions, accounts, and the Lung Key Opinion Leaders located in the Southeast. Essential Duties: Designs, executes, and implements significant national strategic marketing deliverables.

Applies leading-edge clinical and marketplace knowledge and professional concepts to influence the scientific direction of practicing oncologists to support the company and to achieve objectives in creative and effective ways. Expert knowledge of clinical practice and rationale for decision-making in NSCLC. Reputation as a leader in their field across the organization and externally.

A strategic leader and role model within the commercial team. Acutely aware of the impact of decisions across the business and acts with enterprise point of view. Collaborates with senior internal and external representatives to achieve objectives.

Acts independently to determine methods and procedures on new assignments. Supports the US launch of RevMed molecules in the lung cancer marketplace and guides marketers supporting field team regarding customer needs. Acts as an ambassador of the company.

Cultivates exceptional partnerships with external KOLs and partners, understands sentiments and influences commercial strategy with internal partners and stakeholders. Leads the development of Key Account engagement plans and congress plans for each assigned KOL for the commercial team. Plays a key role in enabling and influencing the understanding and opinion of diseases, mechanisms of diseases, and the potential role of products in the management of these diseases using on-label and approved marketing material.

Executes integrated commercial and marketing strategic plans at national/regional scientific meetings with collaborative and aligned purpose. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization. Develops promotional peer-to-peer content and programming including product theaters and other conference promotional education in alignment with annual congress plan.

Develops and executes integrated commercial advisory boards to gain insights that will inform brand strategies. Contributes actively on all key marketing deliverables including QBR, brand/tactical planning, and Launch Readiness Reviews.